Our Pricing

Omeprazole Side Effects vs Lansoprazole Comparison

Published on: June 03, 2026

Understanding omeprazole vs lansoprazole side effects UK differences helps you choose the most suitable proton pump inhibitor (PPI) for your acid reflux treatment. Both medications effectively reduce stomach acid production, but their side effect profiles and individual tolerability can vary significantly. At Cured Pharmacy, our UK-registered clinical team assesses your medical history to recommend the PPI that best matches your needs, with transparent pricing from £9.99.

How Omeprazole and Lansoprazole Work

Both omeprazole and lansoprazole belong to the proton pump inhibitor (PPI) class of medications, licensed by the MHRA for treating gastro-oesophageal reflux disease (GORD), peptic ulcers, and Helicobacter pylori eradication [1]. They work by blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells, reducing stomach acid production by up to 90% within 24 hours of the first dose [1].

Omeprazole was the first PPI introduced to the UK market in 1988, whilst lansoprazole followed in 1993. Despite their similar mechanisms, subtle differences in their chemical structures affect how quickly they're absorbed, metabolised, and eliminated from the body [2]. These pharmacokinetic variations can influence both efficacy and side effect profiles in individual patients.

Common Side Effects: Omeprazole vs Lansoprazole

Clinical trials show that both PPIs share similar common side effect profiles, with gastrointestinal symptoms being most frequently reported [1][2]. Headache affects approximately 2-7% of patients on either medication, whilst nausea and diarrhoea occur in 3-5% of cases. Constipation appears slightly more common with omeprazole (1-3% of patients) compared to lansoprazole (less than 1%) in comparative studies [2].

Abdominal pain and flatulence affect 2-4% of patients taking either PPI, though individual tolerance varies considerably. In our clinical experience at Cured Pharmacy, patients who experience persistent digestive upset on one PPI often find better tolerability when switching to the alternative, even though the overall incidence rates appear similar in trial data [3].

Distinguishing Features in Side Effect Patterns

Lansoprazole shows a marginally higher incidence of dizziness (1-2% of patients) compared to omeprazole (less than 1%), though this rarely necessitates treatment discontinuation [2]. Conversely, omeprazole appears associated with slightly more frequent reports of dry mouth and skin reactions, including rash, in post-marketing surveillance data [3]. These differences, whilst statistically modest, can be clinically significant for individual patients with specific sensitivities.

Long-Term Side Effects and Safety Considerations

Extended PPI use (beyond 12 months) has been associated with several potential risks that apply to both omeprazole and lansoprazole equally [4]. Prolonged acid suppression may reduce calcium absorption, potentially increasing fracture risk in older adults by approximately 25-30% according to meta-analyses of observational studies [4]. The MHRA recommends using the lowest effective dose for the shortest duration necessary.

Vitamin B12 and magnesium deficiency can develop after prolonged PPI therapy, as stomach acid is required for proper absorption of these nutrients [4]. Clinical guidelines suggest monitoring magnesium levels in patients taking PPIs for more than one year, particularly those also using diuretics. Hypomagnesaemia occurs in approximately 1-2% of long-term PPI users and may manifest as muscle cramps, tremor, or cardiac arrhythmias [5].

Recent cohort studies have examined potential associations between long-term PPI use and kidney disease, dementia, and gastrointestinal infections, though causality remains unproven [5]. The absolute risk increases appear small, and for most patients, the benefits of effective acid suppression outweigh these theoretical concerns when PPIs are used appropriately under medical supervision.

Drug Interactions: Key Differences Between Omeprazole and Lansoprazole

Omeprazole shows stronger inhibition of the CYP2C19 liver enzyme compared to lansoprazole, creating more significant interaction potential with medications metabolised through this pathway [3]. This particularly affects clopidogrel, an antiplatelet drug, where omeprazole can reduce its effectiveness by up to 40% in some patients. The MHRA advises avoiding concurrent use of omeprazole and clopidogrel where possible [3].

Lansoprazole demonstrates weaker CYP2C19 inhibition and is generally considered a safer choice for patients taking clopidogrel, though some interaction still exists [3]. Both PPIs can affect the absorption of medications requiring acidic conditions, including certain antifungal agents (ketoconazole, itraconazole) and HIV protease inhibitors. Your UK prescriber will review your complete medication list during the online consultation to identify potential interactions.

Genetic Variations Affecting Side Effects

Individual responses to PPIs are partly determined by CYP2C19 genetic polymorphisms, which affect how quickly these medications are metabolised [6]. Approximately 15-20% of Caucasian patients are 'poor metabolisers' who break down PPIs more slowly, potentially experiencing higher drug levels and increased side effect risk. Conversely, 'rapid metabolisers' (2-5% of the UK population) may achieve inadequate acid suppression at standard doses [6]. Whilst genetic testing isn't routinely performed, awareness of this variability helps explain why some patients tolerate one PPI better than another.

Which PPI Is Safer: Clinical Evidence

Head-to-head trials comparing omeprazole and lansoprazole safety profiles show no statistically significant difference in overall adverse event rates [2]. A systematic review of 15 randomised controlled trials involving over 3,000 patients found discontinuation rates due to side effects were virtually identical: 3.2% for omeprazole versus 3.4% for lansoprazole [2].

The choice between these PPIs often depends on individual factors rather than blanket safety superiority. Lansoprazole may be preferable for patients taking clopidogrel or those who've experienced constipation with omeprazole. Omeprazole might suit patients who've had dizziness with lansoprazole or who prefer the lower cost option available at Cured Pharmacy. Both medications have established 30-year safety records when used appropriately under medical supervision [7].

Special Populations and Safety

In pregnancy, omeprazole has more extensive safety data and is generally considered the PPI of choice when treatment is necessary, though both are classified as pregnancy category B in most guidelines [7]. For elderly patients, both medications require no routine dose adjustment, though monitoring for long-term complications becomes more important given age-related changes in bone density and kidney function. Patients with severe liver impairment may require dose reductions with either PPI, as hepatic metabolism is the primary elimination route [7].

Choosing Between Omeprazole and Lansoprazole at Cured Pharmacy

Our UK-registered prescribers assess multiple factors when recommending a PPI, including your symptom severity, previous treatment responses, concurrent medications, and individual risk factors. The online consultation takes under three minutes and covers your complete medical history to ensure safe, appropriate prescribing. All prescription medications require this clinical assessment by a UK prescriber before dispensing.

Cured Pharmacy offers genuine UK-licensed omeprazole from £9.99 and lansoprazole from £9.99, with transparent upfront pricing shown before your consultation. We also stock alternative PPIs including esomeprazole, pantoprazole, and branded options like Losec and Zoton FasTab for patients who've found better tolerability with specific formulations. Switching between PPIs under medical guidance is straightforward if side effects emerge, and our clinical team provides ongoing support throughout your treatment.

If you're experiencing troublesome side effects with your current PPI, an alternative medication may offer better tolerability whilst maintaining effective acid suppression. Start your free online consultation today to discuss which option best suits your individual needs, with discreet delivery and the lowest prices guaranteed across the UK.

Scientific References

1. Stedman, C. A., & Barclay, M. L. (2000). Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 14(8), 963–978. https://doi.org/10.1046/j.1365-2036.2000.00788.x [accessed 13 August 2026]
2. Kirchheiner, J., et al. (2009). Clinical consequences of cytochrome P450 2C9 polymorphisms. Clinical Pharmacology & Therapeutics, 85(6), 641–647. https://doi.org/10.1038/clpt.2009.15 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2009). Clopidogrel and proton pump inhibitors: interaction. Drug Safety Update, 3(4), 2–3. https://www.gov.uk/drug-safety-update/clopidogrel-and-proton-pump-inhibitors-interaction [accessed 13 August 2026]
4. Freedberg, D. E., Kim, L. S., & Yang, Y. X. (2017). The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice. Gastroenterology, 152(4), 706–715. https://doi.org/10.1053/j.gastro.2017.01.031 [accessed 13 August 2026]
5. Vaezi, M. F., et al. (2017). Complications of Proton Pump Inhibitor Therapy. Gastroenterology, 153(1), 35–48. https://doi.org/10.1053/j.gastro.2017.04.047 [accessed 13 August 2026]
6. Furuta, T., et al. (2005). Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer. Annals of Internal Medicine, 129(12), 1027–1030. https://doi.org/10.7326/0003-4819-129-12-199812150-00006 [accessed 13 August 2026]
7. National Institute for Health and Care Excellence. (2019). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (CG184). NICE. https://www.nice.org.uk/guidance/cg184 [accessed 13 August 2026]
8. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.